BANK OF AMERICA CORP /DE/
BankPosition in RXRX — Recursion Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in RXRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$7,665,268
-$974,219 QoQ
Shares Held
2,496,831
+18.2% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Sep 30, 2025CallValue
$1,464,000
CallShares
300,000
PutValue
$2,136,952
PutShares
437,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. RXRX ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in RXRX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,665,268 | 2,496,831 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,639,487 | 2,112,345 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,136,952 | 437,900 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $5,973,005 | 1,223,977 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,464,000 | 300,000 | Call | Defined | 2026-02-03 | |
| 2025-06-30 | $6,977,308 | 1,378,915 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $2,034,120 | 402,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $2,615,514 | 516,900 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,095,030 | 207,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $6,797,447 | 1,284,962 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,968,159 | 882,864 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $2,424,812 | 358,700 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $897,558 | 136,200 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $7,680,147 | 1,165,425 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,810,987 | 1,841,465 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,978,049 | 1,702,914 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,916 | 600 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $7,742,829 | 785,277 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,875,511 | 898,760 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $4,590 | 600 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $1,723,461 | 230,718 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,715,255 | 557,010 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,252,570 | 421,864 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,115,933 | 198,866 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $864,605 | 106,217 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $599,148 | 83,680 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,932,226 | 171,175 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $609,924 | 26,507 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $287,510 | 7,877 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||